Benefits and Risks of Antiretroviral Therapy for Perinatal HIV PreventionMary Glenn Fowler, Lynne Mofenson, Maxensia Owor et al.|New England Journal of Medicine|2016Cited by 348
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical TrialPatricia M. Flynn, Taha E. Taha, Mae Cababasay et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2017Cited by 219
Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert PanelAmita Gupta, Amina White, Jyoti S. Mathad et al.|Clinical Infectious Diseases|2015Cited by 65
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum ComponentPatricia M. Flynn, Taha E. Taha, Mae Cababasay et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2021Cited by 63
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and FormulationsMartina Penazzato, Marissa Vicari, Devasena Gnanashanmugam et al.|Clinical Infectious Diseases|2017Cited by 36